Fingerprint
Dive into the research topics of 'Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically